Now in its fourth edition, Osteoporosis is a classic reference on this disease, comprising a tremendous wealth of knowledge in a single source not found elsewhere. Written by renowned experts in the field, this two-volume work is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in which direct care costs for osteoporotic fractures in the United States reach up to $18 billion each year. Worldwide, 200 million women ages 60 to 80 suffer from osteoporosis and have a lifetime risk of fracture between 30% and 40%, continuing to make osteoporosis a critical challenge in medicine.
See more
Current price
€251.42
Original price
€288.99
Save 13%
Delivery/Collection within 10-20 working days
Product Details
Format: Mixed media product
Weight: 6500g
Dimensions: 216 x 276mm
Publication Date: 07 Aug 2013
Publisher: Elsevier Science Publishing Co Inc
Publication City/Country: United States
Language: English
ISBN13: 9780124158535
About
Dr. Marcus is Professor-Emeritus Stanford University where he served on the full-time medical faculty for almost 25 years before joining the Emeritus faculty in 2001. At Stanford he was located at the Veterans Affairs Medical Center Palo Alto California where he served as Director of the Aging Study Unit of the Geriatrics Research Education & Clinical Center from 1982-2001. Dr. Marcus enjoyed a long career as a clinical investigator in the fields of bone and mineral metabolism and osteoporosis medicine. His own research interests included diagnosis and therapy of primary hyperpara-thyroidism interactions of the parathyroid-vitamin D axis with estrogen age-related changes in the growth hormone-IGF axis effects of growth hormone replacement for older men and women metabolic and musculoskeletal effects of resistance exercise in older men and women adolescent bone acquisition and osteoporosis therapeutics. Dr. Marcus' laboratory was a study site for many of the pivotal clinical trials in the osteoporosis field. These include the NIH Post-menopausal Estrogen/Progestin Interventions Trial (PEPI) Merck's Fracture Intervention Trial (FIT) Lilly's Multiple Outcomes of Raloxifene Intervention (MORE) and Lilly's registration trial of recombinant PTH(1-34) in the treatment of postmenopausal women with osteoporosis. In 2001. Dr. Marcus joined the US Affiliate of Eli Lilly & Company to support Lilly's program in Osteoporosis and Skeletal Medicine. From 2003 until his retirement from Lilly in 2008 Dr. Marcus was the lead physician for the Forteo team at Lilly. He has published more than 150 research papers editorials and reviews. Dr. Marcus served as President of the American Society for Bone & Mineral Research in 2000-2001. David W. Dempster PhD is Professor of Clinical Pathology and Cell Biology at Columbia University in New York. He obtained his PhD from the University of Glasgow in Scotland and completed postdoctoral studies in Switzerland and France. Dr. Dempster is a Past President of the International Society of Bone Morphometry and a member of the Scientific Advisory Council of the National Osteoporosis Foundation. He is also a Fellow of the Royal Microscopical Society. Dr. Dempster's iconic micrographs of osteoporotic bone have been widely reproduced in the scientific and popular press including being displayed at the Smithsonian Institution in Washington DC. Dr. Dempster is an Associate Editor of Osteoporosis International and serves on the editorial boards of the Journal of Bone and Mineral Research Bone and the Journal of Clinical Densitometry. His research studies have been continuously supported by the National Institutes of Health for the past 25 years. Dr. Dempster has published over 200 research papers on the pathophysiology and treatment of bone disese. Dr. Cauley DrPH is a Distinguished Professor and Executive Vice Chair Department of Epidemiology Graduate School of Public Health (GSPH) University of Pittsburgh (Pennsylvania). Her primary research interest is the epidemiology of osteoporosis especially the large worldwide ethnic and geographic variability in fracture osteoporosis screening and treatment risk factors for fractures and the consequences of osteoporosis in both men and women. Her research has also focused on women's health and aging falls the interaction between endogenous and exogenous hormones risk factors and disease outcomes. She was principal investigator for several large cohort studies including the Study of Osteoporotic Fractures (SOF) and the Osteoporotic Fractures in Men (MrOS) study. She is a co-investigator for the Study of Women's Health Across the Nation (SWAN) with particular emphases on skeletal health and physical function and body composition changes novel measures of hip strength and the trabecular bone score across menopause. She initiated breast cancer follow-up in SOF and was the first to demonstrate an association between bone mineral density (BMD) and breast cancer suggesting that BMD could be used as a cumulative measure of lifetime exposure to estrogen. Dr. Cauley has authored more than 800 papers for scientific journals and 28 book chapters. She co-edited a book entitled the Epidemiology of Aging published in 2012.
Added to your cart:
(-)
Cart subtotal
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more